CashuAscendis Pharma A/S Sees Positive Shift in Short Selling Sentiment and Investor Confidence3 days ago
CashuAscendis Pharma A/S Sees Declining Short Interest, Indicating Increased Investor Confidenceabout 1 month ago
CashuAscendis Pharma A/S Partners with Orsini to Improve YORVIPATH® Access for Hypoparathyroidism Patients7 months ago
prnewswire.comOrsini chosen by Ascendis to distribute treatment for rare endocrine disorder in the U.S.7 months ago
finance.yahoo.comAllarity Therapeutics Strengthens Leadership with Key Appointments to Accelerate Stenoparib PARP Inhibitor Program9 months ago
finance.yahoo.comBioMarin Stands Firm on 2027 Revenue Target Amid Ascendis Competition, Goldman Sachs Analyst Remains Bullish9 months ago